If I'd invested $1,000 in CSL shares 24 years ago, here's how much I'd have now!

While some companies have lost value or even collapsed since listing, you might be surprised how many ASX 200 shares have rocketed over the long term.

| More on:
Woman looks amazed and shocked as she looks at her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Ltd (ASX: CSL) shares first listed on the ASX way back on 8 June 1994.

The S&P/ASX 200 Index biotechnology company floated for $2.30 per share. But once we take share buybacks into account, the adjusted entry price works out to around 76 cents per share.

We won't go back quite that far.

But here's how much I'd have now if I'd invested $1,000 in CSL shares 24 years ago.

Invest in CSL shares like it's 1999

Investing with perfect hindsight is a wonderful thing.

While some companies have lost value or even collapsed since listing, you might be surprised how many ASX 200 shares have rocketed over the long term.

CSL shares certainly count among the winners.

Back on 16 April 1999, CSL closed the day trading for $4.23 per share.

That means I could have bought 236 shares with my $1,000 and had enough left over for a cup of 1999-priced coffee.

At the time of writing, CSL is trading for $304.31 per share.

If I opted to sell those 236 shares today they'd get me a whopping $71,817 and change.

In other words, the stock would have seen me gain 7,081% on my initial investment over 24 years, from share price appreciation alone.

Don't forget the dividends!

But let's not forget that CSL shares also have a lengthy track record of delivering dividends.

According to my calculations, the biotech company has paid out approximately $28 per share in dividends since April 1999. That's more than six times what I would have paid for those shares in 1999.

Assuming I didn't reinvest those dividends but simply tucked the cash under my mattress for a rainy day, I'd have earned some $6,608 in passive income from my 236 shares.

Adding that in, my total gains on that $1,000 investment in 1999 have leapt to an eye-popping 7,742%.

Granted, inflation over that period will have cut those gains roughly in half in real terms.

But still, try getting that kind of yield from your bank!

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »